Frontiers in Neurology & Neuromuscular Research 2026 will convene world-leading neurologists, neuroscientists, geneticists, clinician-scientists, and AI innovators on September 23–24, 2026, in London, United Kingdom. Guided by the theme “Integrating Genomics, AI and Neurotechnology in Neurology & Neuromuscular Medicine,” this premier international congress marks a decisive transition in neurology—from descriptive and symptomatic care toward molecular intervention, intelligent diagnostics, and restorative neurotechnology. ​ At a pivotal moment in biomedical science, NeuroFrontiers 2026 explores the powerful convergence of genomic medicine, artificial intelligence, and neuroengineering. The scientific program will highlight breakthroughs in neurogenomics, multi-omics integration, AI-driven diagnostics, computational neuroscience, neuromuscular therapeutics, brain–machine interfaces, and closed-loop neuromodulation systems. Sessions will examine how generative AI is accelerating drug discovery, how precision gene therapies are reshaping disease trajectories, and how neurotechnologies are enabling recovery and functional restoration previously considered unattainable.